Status:
COMPLETED
Phenotypic Measurements and Their Relation to Disease Exacerbation in COPD Patients
Lead Sponsor:
Massachusetts General Hospital
Collaborating Sponsors:
ResMed
Conditions:
COPD Exacerbation
Copd
Eligibility:
All Genders
18+ years
Brief Summary
This is an observational pilot study focused on collecting data on clinical variables that can improve the understanding of potential predictors of disease exacerbation and readmissions in COPD patien...
Detailed Description
The investigational product to be used in this trial is the ResMed Biomotion Sensor (ResMed Sensor Technologies, Dublin, Ireland). This device uses very low power radio waves (\~1/100th of the strengt...
Eligibility Criteria
Inclusion
- Medically stable and ambulatory COPD (primary diagnosis) patients who have had an emergency room visit or hospitalization for an acute exacerbation of COPD within the past 30 days.
- Sufficient understanding of the English language to be able to read and understand study procedures.
Exclusion
- Currently on admission in the hospital, on non-invasive positive airway pressure ventilation
- Visual, hearing or cognitive impairments at the discretion of their physician.
- Currently participating in a COPD telemonitoring program.
- No AT\&T cellular coverage at their primary residence
- Any other medical or psychological condition that, in the opinion of the investigator may present an unreasonable risk to the study participant as a result of his/her participation in this study, may make participant's participation unreliable, or may interfere with study assessments.
Key Trial Info
Start Date :
December 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2019
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03300739
Start Date
December 1 2016
End Date
September 1 2019
Last Update
September 30 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Partners Connected Health
Boston, Massachusetts, United States, 02114